Mathematical Modeling of Spatio‐Temporal Dynamics of a Single Bone Multicellular Unit
暂无分享,去创建一个
[1] Kosaku Kurata,et al. Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] S. Yamasaki,et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. , 2000, Biochemical and biophysical research communications.
[3] Alexander G Robling,et al. Biomechanical and molecular regulation of bone remodeling. , 2006, Annual review of biomedical engineering.
[4] P. Mantyh,et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord , 2000, Nature Medicine.
[5] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[6] Svetlana V Komarova,et al. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone. , 2005, Endocrinology.
[7] Mark L. Johnson,et al. Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.
[8] S. Mochizuki,et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. , 1998, Endocrinology.
[9] C. Milgrom,et al. Reliable simulations of the human proximal femur by high-order finite element analysis validated by experimental observations. , 2007, Journal of biomechanics.
[10] B. Riggs,et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. , 2000, Endocrinology.
[11] Theo H Smit,et al. Strain-derived canalicular fluid flow regulates osteoclast activity in a remodelling osteon--a proposal. , 2003, Journal of biomechanics.
[12] Olivier Verborgt,et al. Spatial Distribution of Bax and Bcl‐2 in Osteocytes After Bone Fatigue: Complementary Roles in Bone Remodeling Regulation? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] Benedikt Hallgrímsson,et al. Three-dimensional microcomputed tomography imaging of basic multicellular unit-related resorption spaces in human cortical bone. , 2006, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[14] Samuel K. Cho,et al. Mechanical Loading Differentially Regulates Membrane‐Bound and Soluble RANKL Availability in MC3T3‐E1 Cells , 2006, Annals of the New York Academy of Sciences.
[15] L. Xing,et al. Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.
[16] D. Sheppard,et al. α9β1: A Novel Osteoclast Integrin That Regulates Osteoclast Formation and Function , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] D B Burr,et al. Muscle Strength, Bone Mass, and Age‐Related Bone Loss , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] Svetlana V Komarova,et al. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. , 2003, Bone.
[19] Vincent Lemaire,et al. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. , 2004, Journal of theoretical biology.
[20] G. Roodman. Regulation of Osteoclast Differentiation , 2006, Annals of the New York Academy of Sciences.
[21] V. Chernick,et al. Remodeling , 2006 .
[22] H. Frost. Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's Law: The remodeling problem , 1990, The Anatomical record.
[23] David J J de Gorter,et al. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. , 2008, The Journal of bone and joint surgery. American volume.
[24] J. Eisman,et al. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. , 2001, The Journal of endocrinology.
[25] P. Härkönen,et al. Estrogen and Testosterone Use Different Cellular Pathways to Inhibit Osteoclastogenesis and Bone Resorption , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] S. Komarova,et al. Complex Dynamics of Osteoclast Formation and Death in Long-Term Cultures , 2008, PloS one.
[27] David B. Burr,et al. Remodeling and the repair of fatigue damage , 2005, Calcified Tissue International.
[28] Flemming Melsen,et al. Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] Peter Pivonka,et al. Model structure and control of bone remodeling: a theoretical study. , 2008, Bone.
[30] S. Reddy,et al. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. , 1999, The Journal of clinical investigation.
[31] B. Troen. Molecular mechanisms underlying osteoclast formation and activation , 2003, Experimental Gerontology.
[32] T. Martin,et al. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis , 2002 .
[33] Gideon A. Rodan,et al. Control of osteoblast function and regulation of bone mass , 2003, Nature.
[34] S. Reddy. Regulatory mechanisms operative in osteoclasts. , 2004, Critical reviews in eukaryotic gene expression.
[35] T. Martin,et al. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. , 2002, Bone.
[36] T. Martin,et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.
[37] H. Frost,et al. Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: The bone modeling problem , 1990, The Anatomical record.
[38] C. Haipek,et al. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. , 1994, The Journal of biological chemistry.
[39] S. Khosla,et al. Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.
[40] J. Michaeli,et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Parfitt. Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone , 1994, Journal of cellular biochemistry.
[42] G. Roodman,et al. ADAM8: A Novel Osteoclast Stimulating Factor , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] J. Penninger,et al. Role of RANKL and RANK in bone loss and arthritis , 2002, Annals of the rheumatic diseases.
[44] S. Tuck,et al. The cell biology of bone metabolism , 2008, Journal of Clinical Pathology.
[45] M. Padrines,et al. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. , 2004, Biochimica et biophysica acta.
[46] Ruili Li,et al. Interleukin‐11 Receptor Signaling Is Required for Normal Bone Remodeling , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] Kozo Nakamura,et al. Connection Between B Lymphocyte and Osteoclast Differentiation Pathways1 , 2001, The Journal of Immunology.
[48] S. Morony,et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.
[49] L. Lanyon,et al. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. , 2003, American journal of physiology. Cell physiology.
[50] K. Pienta,et al. The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites , 2008, Leukemia.
[51] L. Bonewald,et al. MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] P. Nijweide,et al. Time-lapse microcinematography of osteocytes. , 1995, Mineral and electrolyte metabolism.
[53] M H Kroll,et al. Parathyroid hormone temporal effects on bone formation and resorption , 2000, Bulletin of mathematical biology.
[54] W. Van Hul,et al. Wnt signaling: a win for bone. , 2008, Archives of biochemistry and biophysics.
[55] F. Minuto,et al. The IGF system and bone. , 2005, Journal of endocrinological investigation.
[56] Gethin P Thomas,et al. Vitamin D Action and Regulation of Bone Remodeling: Suppression of Osteoclastogenesis by the Mature Osteoblast , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] Claus Christiansen,et al. Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity? , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[58] T. Martin,et al. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. , 1998, Endocrinology.
[59] B. Riggs,et al. The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated* *This work was supported by Grant AG-04875 from the National Institute on Aging. , 2000, Endocrinology.
[60] Josef M. Penninger,et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.
[61] J. Penninger,et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. , 2000, The Journal of clinical investigation.